239 related articles for article (PubMed ID: 35656103)
1. Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis.
Jiang LP; Yu XH; Chen JZ; Hu M; Zhang YK; Lin HL; Tang WY; He PP; Ouyang XP
Aging Dis; 2022 Jun; 13(3):773-786. PubMed ID: 35656103
[TBL] [Abstract][Full Text] [Related]
2. Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions.
Hoeksema MA; Gijbels MJ; Van den Bossche J; van der Velden S; Sijm A; Neele AE; Seijkens T; Stöger JL; Meiler S; Boshuizen MC; Dallinga-Thie GM; Levels JH; Boon L; Mullican SE; Spann NJ; Cleutjens JP; Glass CK; Lazar MA; de Vries CJ; Biessen EA; Daemen MJ; Lutgens E; de Winther MP
EMBO Mol Med; 2014 Sep; 6(9):1124-32. PubMed ID: 25007801
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting epigenetic enzymes to improve atherogenic macrophage functions.
Van den Bossche J; Neele AE; Hoeksema MA; de Heij F; Boshuizen MC; van der Velden S; de Boer VC; Reedquist KA; de Winther MP
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):396-402. PubMed ID: 25446073
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
Findeisen HM; Gizard F; Zhao Y; Qing H; Heywood EB; Jones KL; Cohn D; Bruemmer D
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):851-60. PubMed ID: 21233448
[TBL] [Abstract][Full Text] [Related]
5. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.
Asare Y; Campbell-James TA; Bokov Y; Yu LL; Prestel M; El Bounkari O; Roth S; Megens RTA; Straub T; Thomas K; Yan G; Schneider M; Ziesch N; Tiedt S; Silvestre-Roig C; Braster Q; Huang Y; Schneider M; Malik R; Haffner C; Liesz A; Soehnlein O; Bernhagen J; Dichgans M
Circ Res; 2020 Aug; 127(6):811-823. PubMed ID: 32546048
[TBL] [Abstract][Full Text] [Related]
6. HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis.
Chen L; Shang C; Wang B; Wang G; Jin Z; Yao F; Yue Z; Bai L; Wang R; Zhao S; Liu E; Wang W
Biochem Pharmacol; 2021 Oct; 192():114716. PubMed ID: 34339713
[TBL] [Abstract][Full Text] [Related]
7. HDAC3 inhibition prevents oxygen glucose deprivation/reoxygenation-induced transendothelial permeability by elevating PPARγ activity in vitro.
Zhao Q; Yu Z; Zhang F; Huang L; Xing C; Liu N; Xu Y; Wang X
J Neurochem; 2019 Apr; 149(2):298-310. PubMed ID: 30347434
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylases and atherosclerosis.
Zheng XX; Zhou T; Wang XA; Tong XH; Ding JW
Atherosclerosis; 2015 Jun; 240(2):355-66. PubMed ID: 25875381
[TBL] [Abstract][Full Text] [Related]
9. Enhancing PPARγ by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice.
Gao Q; Wei A; Chen F; Chen X; Ding W; Ding Z; Wu Z; Du R; Cao W
Pharmacol Res; 2020 Oct; 160():105059. PubMed ID: 32621955
[TBL] [Abstract][Full Text] [Related]
10. CRISPR screen identifies the NCOR/HDAC3 complex as a major suppressor of differentiation in rhabdomyosarcoma.
Phelps MP; Bailey JN; Vleeshouwer-Neumann T; Chen EY
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15090-15095. PubMed ID: 27956629
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.
Jia H; Pallos J; Jacques V; Lau A; Tang B; Cooper A; Syed A; Purcell J; Chen Y; Sharma S; Sangrey GR; Darnell SB; Plasterer H; Sadri-Vakili G; Gottesfeld JM; Thompson LM; Rusche JR; Marsh JL; Thomas EA
Neurobiol Dis; 2012 May; 46(2):351-61. PubMed ID: 22590724
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
[No Abstract] [Full Text] [Related]
13. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
Rudijanto A
Acta Med Indones; 2007; 39(2):86-93. PubMed ID: 17933075
[TBL] [Abstract][Full Text] [Related]
14. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
15. Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy.
Adhikari N; Jha T; Ghosh B
J Med Chem; 2021 Jul; 64(13):8827-8869. PubMed ID: 34161101
[TBL] [Abstract][Full Text] [Related]
16. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
[TBL] [Abstract][Full Text] [Related]
17. Histone Deacetylase 3 Regulates Adipocyte Phenotype at Early Stages of Differentiation.
Cricrí D; Coppi L; Pedretti S; Mitro N; Caruso D; De Fabiani E; Crestani M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502211
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of selective histone deacetylase 3 inhibition.
Zhang L; Chen Y; Jiang Q; Song W; Zhang L
Eur J Med Chem; 2019 Jan; 162():534-542. PubMed ID: 30472601
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
[TBL] [Abstract][Full Text] [Related]
20. The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis.
Zhao TC; Wang Z; Zhao TY
Atherosclerosis; 2020 Jun; 303():36-42. PubMed ID: 32535412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
